Insider Terminal | SEC Intelligence

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
VIR S Vir Biotechnology, Inc. SATO VICKI L • Director 10b5-1 Sell 2026-03-02 $209,181x2 View Form 4 →
VIR	Vir Biotechnology, Inc.	SATO VICKI L Director 10b5-1 Sell	2026-03-02	$209,181x2	S	Form 4
VIR S Vir Biotechnology, Inc. de Verneuil Vanina • Officer • EVP, General Counsel, Corp Sec 10b5-1 SellΔOwn -10.8% 2026-02-25 $134,534 View Form 4 →
VIR	Vir Biotechnology, Inc.	de Verneuil Vanina Officer • EVP, General Counsel, Corp Sec 10b5-1 SellΔOwn -10.8%	2026-02-25	$134,534	S	Form 4
VIR S Vir Biotechnology, Inc. Eisner Mark • Officer • EVP and Chief Medical Officer 10b5-1 Sell 2026-02-25 $18,550 View Form 4 →
VIR	Vir Biotechnology, Inc.	Eisner Mark Officer • EVP and Chief Medical Officer 10b5-1 Sell	2026-02-25	$18,550	S	Form 4
VIR S Vir Biotechnology, Inc. De Backer Marianne • CEO Sell to Cover 2026-02-24 $140,720 View Form 4 →
VIR	Vir Biotechnology, Inc.	De Backer Marianne CEO Sell to Cover	2026-02-24	$140,720	S	Form 4
VIR S Vir Biotechnology, Inc. de Verneuil Vanina • Officer • EVP, General Counsel, Corp Sec Sell to Cover 2026-02-24 $29,713 View Form 4 →
VIR	Vir Biotechnology, Inc.	de Verneuil Vanina Officer • EVP, General Counsel, Corp Sec Sell to Cover	2026-02-24	$29,713	S	Form 4
VIR S Vir Biotechnology, Inc. Eisner Mark • Officer • EVP and Chief Medical Officer Sell to Cover 2026-02-24 $15,405 View Form 4 →
VIR	Vir Biotechnology, Inc.	Eisner Mark Officer • EVP and Chief Medical Officer Sell to Cover	2026-02-24	$15,405	S	Form 4
VIR S Vir Biotechnology, Inc. O'Byrne Jason • CFO Sell to Cover 2026-02-24 $15,576 View Form 4 →
VIR	Vir Biotechnology, Inc.	O'Byrne Jason CFO Sell to Cover	2026-02-24	$15,576	S	Form 4
VIR S Vir Biotechnology, Inc. Sabatini Brent • Officer • SVP, Chief Accounting Officer Sell to Cover 2026-02-24 $13,632 View Form 4 →
VIR	Vir Biotechnology, Inc.	Sabatini Brent Officer • SVP, Chief Accounting Officer Sell to Cover	2026-02-24	$13,632	S	Form 4
VIR M Vir Biotechnology, Inc. SATO VICKI L • Director Other 2026-02-24 $62,930 View Form 4 →
VIR	Vir Biotechnology, Inc.	SATO VICKI L Director Other	2026-02-24	$62,930	M	Form 4
VIR S Vir Biotechnology, Inc. SATO VICKI L • Director 10b5-1 Sell 2026-02-24 $413,366x2 View Form 4 →
VIR	Vir Biotechnology, Inc.	SATO VICKI L Director 10b5-1 Sell	2026-02-24	$413,366x2	S	Form 4
VIR S Vir Biotechnology, Inc. De Backer Marianne • CEO Sell to Cover 2026-02-23 $141,894 View Form 4 →
VIR	Vir Biotechnology, Inc.	De Backer Marianne CEO Sell to Cover	2026-02-23	$141,894	S	Form 4
VIR S Vir Biotechnology, Inc. de Verneuil Vanina • Officer • EVP, General Counsel, Corp Sec Sell to Cover 2026-02-23 $33,128 View Form 4 →
VIR	Vir Biotechnology, Inc.	de Verneuil Vanina Officer • EVP, General Counsel, Corp Sec Sell to Cover	2026-02-23	$33,128	S	Form 4
VIR S Vir Biotechnology, Inc. Eisner Mark • Officer • EVP and Chief Medical Officer Sell to Cover 2026-02-23 $15,569 View Form 4 →
VIR	Vir Biotechnology, Inc.	Eisner Mark Officer • EVP and Chief Medical Officer Sell to Cover	2026-02-23	$15,569	S	Form 4
VIR S Vir Biotechnology, Inc. O'Byrne Jason • CFO Sell to Cover 2026-02-23 $15,569 View Form 4 →
VIR	Vir Biotechnology, Inc.	O'Byrne Jason CFO Sell to Cover	2026-02-23	$15,569	S	Form 4
VIR S Vir Biotechnology, Inc. Sabatini Brent • Officer • SVP, Chief Accounting Officer Sell to Cover 2026-02-23 $13,631 View Form 4 →
VIR	Vir Biotechnology, Inc.	Sabatini Brent Officer • SVP, Chief Accounting Officer Sell to Cover	2026-02-23	$13,631	S	Form 4
VIR S Vir Biotechnology, Inc. Sabatini Brent • Officer • SVP, Chief Accounting Officer Sell to Cover 2026-02-13 $11,919 View Form 4 →
VIR	Vir Biotechnology, Inc.	Sabatini Brent Officer • SVP, Chief Accounting Officer Sell to Cover	2026-02-13	$11,919	S	Form 4